Skip to main content
Industrial Health logoLink to Industrial Health
. 2015 Nov 3;54(2):101–115. doi: 10.2486/indhealth.2015-0071

Amines as occupational hazards for visual disturbance

Jae-Kil JANG 1
PMCID: PMC4821893  PMID: 26538000

Abstract

Various amines, such as triethylamine and N,N-dimethylethylamine, have been reported to cause glaucopsia in workers employed in epoxy, foundry, and polyurethane foam industries. This symptom has been related to corneal edema and vesicular collection of fluid within the corneal subepithelial cells. Exposure to amine vapors for 30 min to several hours leads to blurring of vision, a blue-grey appearance of objects, and halos around lights, that are probably reversible. Concentration-effect relationships have been established. The visual disturbance is considered a nuisance, as it could cause onsite accidents, impair work efficiency, and create difficulties in driving back home. Occupational exposure limits have been established for some amines, but there is shortage of criteria. Volatility factors, such as vapor pressure, should be considered in industrial settings to prevent human ocular risks, while trying to reduce levels of hazardous amines in the atmosphere.

Keywords: Glaucopsia, Visual disturbance, Amine, Polyurethane foam, Foundry, Catalyst

Introduction

An amine forms when one or more hydrogen atoms of ammonia are replaced by particular radicals. Aliphatic amines include alkyl and/or alkanol radicals, whereas heterocyclic amines hold nitrogen in the cyclic ring. When amines contain alcohol radicals, they are also called alkanol amines. One, two, or three nitrogen atoms can be substituted on amines, which classify them into primary, secondary, or tertiary amines, respectively. Most amines have an unpleasant fish-like odor and alkaline characteristics1, 2).

The earliest reports describing irritation and the visual effects of various industrial amines were by Watrous et al.3), and visual disturbance or glaucopsia from various amines was probably first summarized by Amor in the late 1940s3, 4). Glaucopsia comes from the Greek word ‘glauke’ which means ‘blue’ or ‘green2, 5, 6) and workers suffering from these symptoms may have ‘halo’, ‘blue haze’ or ‘foggy vision6,7,8). These ocular effects were induced 30–90 min after exposure to the chemicals and did not give a permanent damage to human eyes. A natural healing process might occur 4–6 h after exposure ended7).

During the second half of the 1900s, several studies reported occurrence of ocular hazards among employees working with epoxy9) and in foundries10,11,12,13,14,15,16,17,18) that require various amine catalysts. Polyurethane (PU) foam factories, which used amines for binding catalysts, were sites where glaucopsia might be occured19,20,21,22,23,24,25). The B-side solution, which mainly consisted of polyol (one type of alcohol) contains about 1% amines, whereas the A-side solution contained isocyanate compounds, such as toluene diisocyanate (TDI) and methylene bisphenyl isocyanate (MDI)26). When these two solutions are mixed under certain conditions, they undergo a urethane reaction. Amine catalysts played an important role accelerating polymerization of isocyanate monomers. In the early 2000s, the US National Institute for Occupational Safety and Health (US-NIOSH)27,28,29) issued reports and a journal article that investigated several amines related to glaucopsia in a printing shop. These compounds had not been reported previously. At the same time, triethylamine (TEA) was reported to cause visual disturbances in Japanese foundry workers30).

Glaucopsia was not considered a serious occupational disorder for workers, as it neither poisoned them, caused irreversible damage, nor led to death. However, the ocular effects resulted in physical accidents, decreased work efficiency, and impaired of task coordination. In addition, it was a workplace hazard, similar to irritation of skin or mucous membrane, and thus required control measures to restrict employees’ contact with causing chemicals in the work environment6, 7).

Dozens of occupational disorder cases were reported from a PU foam manufacturing plant in Korea31, 32). Workers in a passenger car seat plant experienced various visual disooders, including difficulties focusing, eye discomfort, and halo vision while driving back to home after work. Nevertheless, little information was extracted from existing workplace monitoring data or medical examination records at the plant. It was apparent that the employer was attempting to identify the cause for the problems while trying to improve the situation by installing of local ventilation systems, rotating tasks, and clinical treating affected workers. The situation was particularly aggravated during the summer and nearly all workers in the process suffered glaucopsia symptoms. The Occupational Safety and Health Research Institute (OSHRI) of the Korea Occupational Safety and Health Agency (KOSHA) tried to resolve the issue after the agency received a safety and health evaluation request from the plant. Substituting for amines in raw materials could make it possible to resolve the problem successfully. In the present study, data obtained from the literature that describes glaucopsia and its relationship to various amines are summarized.

Methods

Journal articles were retrieved from online resources, including PubMed, TOXNET, ScienceDirect, Scoup, and Google Scholar utilizing random combinations of key words, such as ‘glaucopsia’, ‘amine’, ‘halo vision’, blurry vision’, ‘blue-grey haze’ and ‘visual disturbance’. The National Digital Science Library (NDSL) which is operated by the Korea Institute of Science and Technology Information (KISTI), which is provides 53 million scientific English articles in SCI, SCIE, and Scoup journals, was also searched. The journal search was conducted during winter 2014 and early 2015 without a year restriction. To obtain US-NIOSH research and Health Hazard Evaluation (HHE) reports, the homepage was searched using the same keywords. Amines with occupational exposure limits (OEL) in the Documentation of Threshold Limit Values which includes about 700 chemicals’ Threshold Limit Values (TLVs) with around dozens amines, published by the American Conference of Governmental Industrial Hygienists (ACGIH), were also chased. Workplace Exposure Limits (WEL) of UK Health and Safety Executive (UK-HSE) were also obtained for information. Due to the relative restriction of journal articles and reports available on visual risks, nearly all references cited by important studies were traced and obtained.

Results

Historical background and glaucopsia amine chemicals

Numerous studies have considered topics related to the negative effects of amines on vision since Amor4) published his article illustrating the toxicity of various solvents. One of the earliest occupational cases of visual disturbance due to diisopropylamine (DIPA) in a plant was reported by Treon et al.33) after exposure to dozens ppm concentrations, which had been informed to the authors personally. After this article was published, many studies have followed and discussed occupational glaucopsia related to amine compounds during the last decades. Extensive human and animal data are available on some amines, such as TEA and dimethyethylamine (DMEA), whereas others have relatively restricted and/or outdated information. Several books and review articles written by Cavender1), Grant & Schuman2), Albrecht6), Ballantyne7), and Johns & Kipling8) contain valuable information about glaucopsia-inducing amine chemicals.

Twenty-one important amines could be listed in this review, including ethyl amine (EA)2, 4, 8, 34,35,36,37), isopropylamine (IPA)36,37,38,39), tert-octylamine (TOA)2, 7, 8, 40), ethylenediamine (EDA)2, 7, 36,37,38,39,40,41,42), dimethylamine (DMA)2, 7, 8, 36, 37, 40, 43,44,45,46), diethylamine (DEA)2, 7, 36, 37, 47, 48), DIPA2, 7, 33, 36, 37, 49, 50), DMEA6, 7, 10,11,12,13,14,15,16, 51), TEA4, 6, 7, 10, 11, 17, 18, 23, 24, 30, 36, 37, 44, 52,53,54,55,56,57,58), N-ethylpiperidien (EPP)2, 7, 8, 43, 44), 3-dimethylaminopropylamie (DMAPA)7, 59), triethylenediamine (TEDA)6, 7, 20, 22, 24, 25, 60), N,N,N’N’-tetramethyl-1,2-ethylenediamine (TMEDA)2, 7, 8, 43, 44), N,N,N’,N’-tetramethyl-1,3-butanedimine (TMBDA)2, 6, 7, 20, 60), bis[2-dimethylaminoethyl]ether (DMAEE)7, 25, 36, 37, 44, 61,62,63,64), N,N,N’,N’-tetramethyl-1,6-hexandianine (TMHDA)31, 32), morpholine (MP)2, 6,7,8, 19, 20, 36, 37, 65,66,67), N-methylmorpholine (MMP)2, 6,7,8, 19, 20, 22, 42, 44), N-ethylmorpholine (EMP)2, 7, 8, 19, 20, 36, 37, 43, 44, 68, 69), NN,-dimethyaminoethanolamine (DMAEA)27,28,29), and N,N-dimethyisopropanolamine (DMIPA)27,28,29). Among them EA, IPA, TOA, EDA, DEA, DIPA, EPP, DMAPA, TMEDA, TMBDA, and TMHDA have minimal human data and/or outdated background information published before 1970, including industry reports. Neither articles nor toxicology textbooks that have cited or recited basic original human data were considered here.

Other amines, including DMA, DMEA, TEA, TEDA, DMAEE, MP, MMP, EMP, DMAEA, and DMIPA have moderate to large quantities of background information on their glaucopsia hazards. Henceforth, this review mainly focuses on reviewing the ocular hazards of amines with significant human data, except TMHDA, which is a cases of recent workplace exposure.

Physical and chemical characteristics of important amines

Table 1 summarizes the physical and chemical properties of the important 11 amines which include chemical catalysts in various industrial processes. Except for DMA, which is a gas at normal temperature (20°C) and pressure (1 atm), many of them exist in liquid form. MP, MMP, and EMP can be categorized into a heterocyclic group, while DMIPA is an alkanol amine. Table 1 was compiled considering groups of amines, the number of amines in the molecular structure, and molecular weight (MW) of each compound. DMA has the simplest molecular structure, whereas DMAEE and TMHDA have MW of more than 160.

Table 1. The list of amines that may cause human glaucopsia.

Chemical name Abbreviation CAS No. Chemical group Molecular form MW MP (°C) BP (°C) VP (mmHg)
Dimethylamine DMA 124-40-3 secondary amine (CH3)2NH 45.1 –92.2 6.8 1,520
N,N-Dimethylethylamine DMEA 598-56-1 tertiary amine (CH3)3CH2N 73.1 –140 36.5 418
Triethylamine TEA 121-44-8 tertiary amine (CH3CH2)3N 101.2 –114.7 89.3 57.1
Triethylenediamine TEDA 280-57-9 tertiary diamine (CH2)6N2 112.2 158 174 0.742
Bis[2-dimethylaminoethyl]ether DMAEE 3033-62-3 tertiary diamine O[(CH3)2(CH2)2N]2 160.3 NA 189 0.748
N,N,N’,N’-Tetramethyl-1,6-hexandianine TMHDA 111-18-2 tertiary diamine [(CH3)2(CH2)3]2N2 172.3 –46 209.5 0.202
Morpholine MP 110-91-8 heterocyclic amine O(CH2)4NH 87.1 –4.8 128 10.1
N-Methylmorpholine MMP 109-02-4 heterocyclic amine O(CH2)4CH3N 101.2 –66 115.5 18
N-Ethylmorpholine EMP 100-74-3 heterocyclic amine O(CH2)5CH3N 115.2 –62.8 138.5 6.1
N,N-Dimethylaminoethanolamine DMAEA 108-01-0 Alkanol amine HO(CH3)2(CH2)2N 89.1 –70 135 100
N,N-Dimethylisopropanolamine DMIPA 108-16-7 Alkanol amine HO(CH3)3CH2CHN 103.2 –85 96 8

Vapor pressure (VP) is a very important property, as it denotes an ideal theoretical concentration in air at normal temperature and pressure (NTP), which could be a workers’ exposure concentration when the air is saturated with the chemical in a confined environment without ventilation. The boiling point (BP) and melting point (MP) are critical to determine an agent’s physical form (gas, liquid, or solid) at NTP. Abbreviations have been used for each amine to describe the chemicals as simply as possible.

Dimethylamine

DMA belongs to a group of secondary amines and has huge VP of 1,520 mmHg. Munn reported several ocular hazard cases resulting from industrial exposure to this chemical without detailed background information40). Ballantyne cited Munn’s report in his study to summarize toxicity data7). When Mellerio & Weale decided to conduct animal experiment on several amines including DMA43), they considered ocular hazards, and their study was cited by Grant & Schuman2), Jones & Kipling8) and Ballantyne44) for studies on glaucopsia in workers. However, Hathaway & Proctor simply reported occasional dermatitis or conjunctivitis after prolonged exposure to this compound based on the 1955 MCA Inc. chemical safety data sheet45). ACGIH documentation indicates dermal, ocular, respiratory, and gastrointestinal track irritation caused by this compound, as evidenced in animal tests46).

N,N-dimethylethylamine

DMEA is also called dimethylethylamine and is a tertiary amine. Its effects on the eye in industrial workers have been well examined. Since Schmitter investigated workers’ hazy blue-grey vision in a Germany foundry using cold-box and shell mold casting methods in 197711), various studies have discussed DMEA as a catalyst and as a chemical that causes visual disturbances (Table 2). Studies that only considered sampling and analytical methods are not included in the table. Except for one review article written by Ballantyne7) most of the studies were published before the beginning of this century.

Table 2. Articles describing human glaucopsia caused by DMEA.

Author (s) Year Type Reference
Schmitter 1977 Original 11)
Albrecht & Stephenson 1988 Review 6)
Warren & Selchan 1988 Original 10)
Ståhlbom et al. 1994 Original 51)
Ballantyne 2004 Review 7)
US-NIOSH 1984 Report 12)
US-NIOSH 1984 Report 13)
US-NIOSH 1986 Report 14)
US-NIOSH 1987 Report 15)
US-NIOSH 1987 Report 16)

US-NIOSH investigated several factories where glaucopsia cases had been reported in their HHE efforts12,13,14,15,16), but some failed to detect amines in workplace air. Warren & Selchan10) conducted a survey study on workers exposed to DMEA with TEA in 42 foundries. StÅhlbom et al.51) conducted personal exposure experiments employing volunteers and found that glaucopsia could occur over a relatively long exposure time at low concentrations, whereas short-term exposure to high levels led to eye irritation.

Triethylamine

TEA has the most abundant data on its glaucopsia hazards. Since Amor designated the hazards of this chemical4), visual disturbances have been reported occasionally in foundries and PU industries until the early 2000s, including a Japanese episode30). Studies by Hathaway & Proctor52) and ACGIH53) have reported detailed toxicity data on the visual disturbances caused by TEA.

Åkesson and his colleagues performed several human experiments to reveal the ocular toxicity mechanism of TEA and explained that the visual disturbance might be caused by corneal edema. They also suggested that triethylamine-N-oxide (TEAO) could be a human biological index for overexposure to the chemical, whereas alcohols such as ethanol might inhibit metabolism of TEA to TEAO23, 55, 57, 58). Jävinen and coworkers carried out a case-control study18) and an intentional human exposure study56). Important studies that reported the ocular hazards of TEA are listed in Table 3.

Table 3. Articles describing human glaucopsia caused by TEA.

Author (s) Year Type Reference
Amor 1949 Original 4)
Schmitter 1977 Original 11)
Åkesson et al. 1985 Original 54)
Åkesson et al. 1986 Original 23)
Potts et al. 1986 Original 24)
Albrecht & Stephenson 1988 Review 6)
Åkesson et al. 1988 Original 55)
Warren Selchan 1988 Original 10)
Åkesson et al. 1989 Original 57)
Åkesson & Skerfving 1990 Original 58)
Reilly et al. 1995 Original 17)
Jävinen & Hyvärinen 1997 Original 18)
Ballantyne 1999 Review 44)
Jävinen et al. 1999 Original 56)
ACGIH 2001 Review 53)
Yoshida et al. 2001 Letter 30)
Ballantyne 2004 Review 7)
Hathaway et al. 2004 Review 52)

Triethylenediamine

TEDA is a tertiary amine, which is occasionally called DAVCO. TEDA is a commercial PU catalyst that was used for decades. TEDA exists as a solid at NTP, with MP of 158°C and BP of 174°C. In their animal toxicity experiments of TEDS and another amine (TMBDA), Goldberg & Johnson did not fully demonstrate distinct ocular effects in mice due to low VP (0.742 mmHg)60), whereas TMBDA (VP=1.64 mmHg) caused profound pupillary dilation and loss of accommodation. Dernehl reported visual disturbances among workers at the Union Carbide Corp. who were exposed to several amines including TEDA and constituted background for his study20); however, he did not definitely determine that TEDA caused the symptoms.

In a letter to the editor of the Journal of Occupational Medicine in 1975, Smith & Henderson commented that TEDA was an eye and respiratory system irritant but did not mention glaucopsia70). In another letter to the editor of same journal in 1976, Pagnotto and Wegman at the Massachusetts Division of Occupational Hygiene, following the designation of Smith & Henderson70), carried out an investigation on a PU foam plant using TEDA71). They also failed to detect TEDA in the workplace atmosphere due to the low sensitivity of their sampling and analytical methods (<0.4 ppm) and did not report any ocular symptoms among workers at the site. Belin et al. examined a PU foam factory in one health investigation of and compared exposed workers to results from an unexposed control group and concluded that MMP, which was detected at the thousand ppb level, could have been the major causative chemical for the respiratory and visual disturbance symptoms rather than TEDA22). They also detected this amine and isocyanates in workroom air, but the concentrations were <0.11 ppb and several ppb, respectively. Balantyne included TEDA in his list of glaucopsia-causing compounds7) citing the Dernehl’s Union Carbide case20). US-NIOSH and the US-Occupational Safety and Health Administration (US-OSHA) have not established any OELs for the compound until today.

Bis[2-dimethylaminoethyl]ether

Although several studies have described workplace exposure to DMAEE vapor as a causative agent of glaucopsia, few real human data are available. Boeniger et al. tried to verify a DMAEE air evaluation method and detected 28–208 ppm DMAEE without describing any visual disturbance effects72). In a case report on a PU foam factory, US-NIOSH described multiple ocular symptoms and determined DMAEE air levels but they failed to detect the compound at the site25).

One scientist at the Union Carbide Corp. with the aid of other experts carried out animal studies on DMAEE and concluded that human glaucopsia could occur due to a transient increase in corneal thickness and corneal edema61,62,63). The researcher also cited relevant studies in his review article7) and in a toxicology textbook44). ACGIH64) has a current TLV of 0.005 ppm (TWA) and 0.15 ppm for STEL due to highly irritating and ocular effects of this amine.

N,N,N’N’-Tetramethyl-1,6-hexanediamine

Recent cases on human visual disturbances in a Korean PU foam factory revealed that TMHDA, a tertiary catalyst amine, was included in the B-side solution with TEDA. According to the clinical records available from the company, nearly 40 workers involved in making several types of PU foams for passenger car seats suffered relatively serious ocular symptoms, including blue-grey vision and halos around lights. The new process and the B-side solution were introduced at the site during the spring, and glaucopsia worsened in June (early summer season) when daytime temperature increased to about 30°C. The factory managers asked OSHRI of KOSHA to investigate the issue after they had attempted to and failed to resolve the problem by introducing local ventilation systems and rotating tasks. The mean air concentrations of TEDA and TMHDA were 0.060 ppm and 0.070 ppm, respectively, after confirming the identities of the chemicals by gas chromatography-mass spectrometry (GC/MS). TEDA and TMHDA are listed by the American Chemical Society (ACC) and the Center for the Polyurethanes Industry in a list of 52 amine catalysts that might be used at PU manufacturing factories73). The supplier of the B-side solution and the factory that had the glaucopsia problem changed amines from non-reactive to reactive foams, which could be chemically combined into PU polymers with a reduction in evaporation of amine vapors at the worksite. Substituting catalysts cut mean atmospheric levels of TEDA and TMHDA to 0.026 ppm and 0.014 ppm, which was about 60% and 80% of previous levels, respectively. Most workers did not experience symptoms in the next summer. This was the first official report on industrial glaucopsia in the country with successful resolution of an occupational issue31, 32).

Morpholine

In 1965, Mastromatteo reported that MP could be a human glaucopsia-causing chemical in several PU foam industries in Ontario, Canada. Symptoms developed at the end of a work-shift and cleared up within hours after exposures19). Dernehl at the Union Carbide Corp. designated the compound as a visual disturbance hazard along with his incomplete findings on the occurrence of eye lesions at MP levels ≥40 ppm20). Johns & Kipling described exposure of 3 to 18 employees to a variety of amine compounds including MP in a chemical plant over several years and the complaints of workers on the presence of blue vision, grey vision, and halos with associated difficulties driving8). A range of amines and their intermediates were manufactured at that plant.

Ballantyne cited the afore-mentioned articles in a chemical review on glaucopsia7). A workplace chemical hazard book edited by Hathaway & Protor65) summarized that workers exposed for hours to low vapor air levels of MP complain of foggy vision with halos around lights as a result of corneal edema. Actually, this information came from one of the chapters of Patty’s toxicology book66), but the data originated from Grant & Schuman’s book2). Following this finding, ACGIH set a TLV-TWA of 20 ppm67). However, the eye toxicology book of Grant simply cited the work of John & Kipling8) and Mastromatteo19). Skin notation was assigned due to the potential irritation effects on the eyes, nose, and throat.

N-methylmorpholine

Mellerio & Weale prompted reports of blue and grey vision among amine plant employees by evaluating ocular effects in animal studies43). Mastromatteo and Dernehl reported human glaucopsia hazards of MMP when present with MP in their articles19, 20). When Jones & Kipling historically reviewed amine chemicals for their effect on blue-grey vision, they mentioned that one of their colleagues experienced grey haziness from intentional exposure to MMP8). Belin et al. investigated workplace exposure levels to MMP at a PU foam factory along with isocyanates and TEDA (DAVCO)22). Forty-two workers reported occasional eye symptoms and the presence of blue light halos. Air levels on production lines were 3.2–7.6 ppm. The concentrations were not TWA levels, instead average of several determinations. Respiratory track symptoms were also reported by workers.

In their review articles, Ballantyne and Jones & Kipling summarized occupational ophthalmic hazards of MMP7, 8). In a general toxicology textbook, Grant & Schuman and Ballantyne also cited the previous studies that pointed out the human ocular risks of MMP2, 44). ACGIH, US-OSHA, and US-NIOSH have not set any OELs for MMP.

N-ethylmorpholine

Due to chemical similarity, EMP was reported by several studies to lead to human glaucopsia. Mastromatteo demonstrated visual hazards caused by EMP in several PU industries with little comment on the onsite process or medical findings19). Dernehl found characteristic corneal lesions in some workers exposed to amine compounds, including EMP20). The workers’ corneas showed diffused clouding and many obscure markings on the iris. When Mellerio & Weale considered animal studies, they reported blue or grey vision and smoky clouds among workers in chemical plants that were caused from several amines, including EMP43). A book edited by Hathaway & Proctor68), toxicology books of Grant & Schuman2) and Ballantyen44), review articles by Ballantyne7) and Jones & Kipling8) have also reported occupational visual disturbances among workers exposed to EMP.

Currently, ACGIH has set a TWA-TLV of 5 ppm for the chemical by adapting references written during the 1960s69), which are also mentioned here. In the TLVs documentation, one additional personal communication by Woewicki explained that workers exposed to 3–4 ppm, but not >11 ppm, complained of foggy vision and optical halos69). These results could be the basis for TLVs but the references were relatively outdated.

N,N-dimethyaminoethanolamine

US-NIOSH received a request for a HHE from a large printing shop located in Ohio, USA in January 2011. About 89% of the line division workers at the factory were suffering from blurry vision, whereas 12.5% of the employees in the prime division had the symptoms. The mean DMAEA concentration at the line division was about 0.62 ppm, which was similar to that of prime division of about 0.95 ppm. No changes in air DMAEA levels were detecting in either division after controlling the amines; however, the ocular effects among workers disappeared. The institute concluded that glaucopsia might have been caused by other amines and that DMAEA was not the culprit at the detected concentration levels27,28,29).

N,N-dimethyisopropanolamine

DMIPA was the other amine at the Ohio printing factory mentioned in the previous DMAEA section, which has a VP of 100 mmHg, whereas that of DMAEA is 8 mmHg. The prime division used DMAEA and the pH adjuster in the line division contained DMIPA27,28,29). The mean DMIPA concentration at the line division was 1.83 ppm and that for the prime division was 0.49 ppm before introducing control measures. By eliminating DMIPA in the line division, it was possible to dramatically reduce the concentration, and visual disturbances among workers disappeared. The institution suspected that the high air levels of DMIPA before introducing the control measures might be caused by the high VP of this substance, as shown in Table 1. Acute irritation toxicity of this chemical was reported by Ballantyne74) in an animal study; however, additional data on human glaucopsia could not be found for this particular alkylalkanol amine.

Discussion

Amine processes related to glaucopsia

Amines have been used extensively as starting materials for chemical syntheses, as intermediates, and as solvents in numerous industrial processes. Amines are used intensively in catalysts, poultry feed, corrosion inhibitors, drugs, bactericides, and herbicides1). Considering the glaucopsia hazards due to various amines, the processes employing such compounds were relatively restricted. Early visual disturbance cases originated from some chemical factories33, 59); however, two major reported industrial sites were foundries and PU foam factories (Table 4).

Table 4. Industrial processes for glaucopsia and irritation hazards.

Process Amines References (glaucopsia) References (irritation)
PU foam TEA, TEDA, DMAEE, TMHDA, MP, MMP, EMP, DEtA* 7, 19,20,21,22,23,24,25, 31, 32, 60) 61, 71, 75, 76)
Foundry DMEA, TEA, HMTA** 10, 14, 20, 26, 30,31,32) 15, 77,78,79,80)
Epoxy Other amines# 9) 81, 82)
Printing DMAEA, DMIPA, 27,28,29)
Others DMA, MMP, EMP 43) 3, 43)

*DEtA: diethanolamine

**HMTA: hexamethylenetetramine

#Other amines include m-phenylenediamine, triethylenetetramine, dimethylethanolamine, diethylenetriamine, dimethylaminopropylamine, diethylaminopropylamine, and benzyldimethylamine

The chemicals that can cause glaucopsia and those that may be occupational irritation hazards are included in Table 4 to warn occupational health practitioners. Also, several special amines that are not listed in Table 1 have been included in Table 4 following the same intention. Eight amines used in PU foam factories were appropriate to the list, including diethanolamine (DEtA), which could not be traced in Table 1. MP, MMP, and EMP had long history of PU industry use since the 1960s, whereas other amines have been used since 1980. DMEA, TEA, and hexamethylenetetramine (HMTA) have been employed in foundries as cold-box curing catalysts and workers might be exposed to the vapor when the injecting amines into sand molds for hardening. Several amines not listed in Table 1 were used as epoxy resin binders but their effects were mainly irritations rather than visual disturbances. Other processes described in Table 4 include chemical plants and pharmacological factories, and glaucopsia has been associated with exposure to DMA, MMP, and EMP43). Irritation symptoms in workers exposed to DMA could be due to chlorinated DMA but this has not been clearly explained6). Recently, DMAEA and DMIPA that caused ocular hazards were reported to be used in a US printing shop27,28,29), which previously was not included in processes causing a visual disturbance.

Workers exposure levels to amines

The exposure levels of workers to amines that could cause occupational glaucopsia have been reported with relevance to previous studies (Table 5). Air levels of amines causing irritation were not considered to construct the table. Among the amines in Table 1, TEA, DMEA, TEDA, DMAEA, DMIPA, TMHDA, DMAEE, and MMP have sufficient data to be summarized. There are only limited monitoring data for the other amines. A good number of data are available for TEA and DMEA, whereas information on the other compounds is too restrictive to construct meaningful OELs.

Table 5. Amine exposure levels causing glaucopsia in workers.

Reference Amines Process Type Samples Exposure range Glaucopsia Additional findings
Warren & Selchan10) TEA Foundry Onsite 31 (TWA) 2.6–3.6 ppm* (GM: 3.1 ppm) + No glaucopsia at less than 5 ppm
Foundry Onsite 69 (STEL) 4.5–5.9 ppm* (GM: 2.7 ppm) +
Schmitter11) Foundry Onsite 38 0.1–11.8 ppm (mean: 3.3 ppm) +
Reilly et al.17) Foundry Onsite 17 0.1–4.9 ppm (mean: 1.9 ppm) + Common symptom at >2.5 ppm
Jävinen & Hyvärinen18) Foundry Onsite NA 0.1–14.5 ppm (median: 6.4 ppm) +
Åkesson et al.23) PU Onsite 5 (TWA) 1.2–8.0 ppm (mean: 3.2 ppm) + 2.4–3.6 ppm (TWA) may cause glaucopsia
NA (STEL) ND-5.8 ppm (mean : NA)
Åkesson et al.54) Chamber experiment 2 2.4/4.4/8.2/11.6 ppm +/− Glaucopsia at 4.4 ppm and higher
Åkesson et al.55) Chamber experiment 5 2.4/4.8/8.5/12.8 +/− Glaucopsia at 4.8 ppm and higher
Jävinen et al.56) Chamber experiment 4 0.72/1.58/9.8 ppm +/− Glaucopsia at 1.58 ppm and higher
Åkesson et al.58) Chamber experiment 4 4.8 ppm + Occurrence of glaucopsia

Warren & Selchan10) DMEA Foundry Onsite 54 (TWA) 5.7–6.9 ppm* (GM: 6.3 ppm) + No glaucopsia at less than 5 ppm
Foundry Onsite 151 (STEL) 10.2–11.2.9 ppm* (GM: 10.7 ppm) +
Schmitter11) Foundry Onsite 26 0.001–12.3 ppm (mean: 2.6 ppm) +
US-NIOSH12) Foundry Onsite 4 0.4–0.8 ppm (mean: 0.6 ppm) +
US-NIOSH13) Foundry Onsite 9 1.8–8.8 ppm (mean: 4.4 ppm) +
US-NIOSH15) Foundry Onsite NA NA + Glaucopsis at 2 ppm (TWA) or higher, 9.7 ppm (STEL) or higher
US-NIOSH16) Foundry Onsite 63 (TWA) ND-8.0 ppm (mean: 2.3 ppm) +
30 (STEL) ND-9.7 ppm (mean: 1.6 ppm)
Ståhlbom et al.51) Chamber experiment 4 (TWA) 3.3/6.6/13.3/16.6 ppm +/− No glaucopsia at less than 6.6 ppm
Chamber experiment 30 (STEL) 26.7/53.3 ppm - No glaucopsia with eye irritation
Foundry Onsite 12 0.16–9.3 ppm (mean: 1.2 ppm) + Glaucopsis at 7.6–9.3 ppm

Belin et al.22) TEDA PU Onsite 7 0.017–0.11 ppm (mean: 0.08 ppm) +
US-NIOSH25) PU Onsite NA NA + Failed to detect amines in the air
Jang et al.31) PU Onsite (Pre) 29 ND-0.26 ppm (mean: 0.06 ppm) + Isocyanate and aldehydes detected
Jang & Park32) PU Onsite (Post) 29 ND-0.08 ppm (mean: 0.03 ppm) - Aldehyde levels also reduced

US-NIOSH27) DMAEA Printing Onsite (Pre) 110 0.05–1.24 ppm (mean: 0.66 ppm) +/−
US-NIOSH28) Printing Onsite (Post) 64 0.01–1.37 ppm (mean: 0.76 ppm) - DMAEA was not related to glaucopsia

US-NIOSH27) DMIPA Printing Onsite (Pre) 110 0.16–4.0 ppm (mean: 1.65 ppm) +/− Mean DMIPA (1.83 ppm, N=96) caused glaucopsia
US-NIOSH28) Printing Onsite (Post) 64 0.01–0.09 ppm (mean: 0.02 ppm) - DMIPA related to glaucopsia

Jang et al.31) TMHDA PU Onsite (Pre) 29 ND-0.29 ppm (mean: 0.07 ppm) + Isocyanate and aldehydes detected
Jang & Park32) PU Onsite (Post) 29 ND-0.002 ppm (mean: 0.01 ppm) - Aldehyde levels also reduced

US-NIOSH25) DMAEE PU Onsite NA NA + Failed to detect amines in the air

Belin et al.22) MMP PU Onsite 7 3.2–7.6 ppm (median: 6.9 ppm) + MMP might cause glaucopsia

* Upper and lower 95% confidence limits of the GM

Warren & Selchan did not report glaucopsia hazard at TEA concentrations ≤5 ppm10) and Reilly et al. found that ≤2.5 ppm was a possible threshold level17). According to several intentional human experiments performed by Åkesson and coworkers23, 54, 55, 57, 58) and Jävinen & Hyvärinen18), visual disturbances did not occur when air exposure levels were ≤1 ppm. ACGIH is currently trying to change a TWA-TLV from 1 to 0.5 ppm with a STEL of 1 ppm as per the Notice of Intended Changes (NIC) and this measure should protect workers against glaucopsia36).

Warren & Selchan reported no ocular hazards at DMEA levels ≤5 ppm10). Schmitter and several studies done by NIOSH found that mean levels of several ppm of DMEA were related to glaucopsia11, 13, 14), but one NIOSH study reported that 0.4–0.8 ppm was a possible cause of hazard12). Another NIOSH report described that DMEA concentrations of 2 ppm (TWA) and 9.7 ppm (STEL) might have caused human visual disturbances in an aluminum casting foundry15). In their human experimental studies, StÅhlbom et al. reported that ≤6.6 ppm did not cause glaucopsia51). Minimal data are available to consider occupational threshold values for TEDA. Also, additional data for DMAEA, DMIPA, TMHDA, and MMP are required to set the OELs.

Occupational exposure limits

OELs are critical baselines for chemical specific risk assessments and constructing control options to protect workers from many hazardous substances. Relatively well-accepted criteria include TLVs of ACGIH, Recommended Exposure Limits (RELs) of US-NIOSH, Permissible Exposure Limits (PELs) of US-OSHA, Maximum Concentrations at the Workplace (MAKs) in Germany, and WELs in the United Kingdom. OELs for amines are quite restrictive, as summarized in Table 6, in which only 10 compounds have exposure limits, including four substances listed in Table 136, 37, 83). All 21 amine chemicals listed in the Introduction section were considered to enlist OELs for occupational health professional instructional purposes.

Table 6. Occupational exposure limits of amines for glaucopsia.

Chemical name ACGIH-TLVs73) OSHA-PELs74) NIOSH-RELs74) AIHA-WEEL74) UK HSL-WEL86) German-MAKs74) Skin notation






TLV STEL TLV STEL TLV STEL TLV STEL TLV STEL TLV STEL
Ethylamine 5 15 10 - 10 - - - 2 6 5 C10 ACGIH
Isopropylamine 5 10 5 - - - - - - - 5 C10
Ethylenediamine 10 - 10 - 10 - - - - - - - ACGIH
Dimethylamine* 5 15 10 - 10 - 1 3 2 6 2 -
Diethylamine 5 15 25 - 10 25 - - 5 10 5 C10 ACGIH
Diisopropylamine 5 - 5 - 5 - - - 5 - - - ACGIH/OSHA/NIOSH
Triethylamine 1** 3* 25 - - - - - 2 4 1 ACGIH/HSL
Bis (2-dimethylaminoethyl) ether* 0.005 0.15 - - - - - - - - ACGIH
Morpholine* 20 - 20 - 20 30 10 - 10 20 - - ACGIH/OSHA/NIOSH/HSL
N-Ethylmorpholine* 5 - 20 - 5 - - - 5 20 - - ACGIH/OSHA/NIOSH/HSL

*Amines listed in Table 1 as glaucopsia chemicals, **Notice of intended change in 2014 TLVs

As mentioned previously, fundamental information to develop OELs is relatively restricted due to limited studies available to criteria-setting organizations. In some cases, only one or two human studies are available to set limits and some are outdated33, 38, 39, 49). As it is well known that the reaction between isocyanates and alcohols, such as polyol, follows second-order kinetics, catalyst amines play an important role in the PU reaction75). When the numbers of amino groups in a molecule increases, catalytic activities tend to increase76). Therefore, while uses for tetraamines and triamines have increased, the possibility of occupational exposure to di and monoamines has decreased, which could result in little additional field exposure data for low molecular weight amine compounds in the PU industry.

ACGIH proposed a 0.5 ppm (TWA) NIC for TEA, and the German MAK for the compound is 1 ppm (TWA), whereas the PEL of US-OSHA is 25 ppm (TWA) and the WEL of the UK-HSL is 2 ppm (TWA)36, 37, 83). Despite some valuable DMEA data, none of the organizations has currently set OELs for this compound.

New OELs have been suggested. Ballantyne proposed a 5 ppm OEL for MMP as a EMP homolog7). Most amines are alkali and may induce skin, mucous membrane, and respiratory tract irritation. Considering these symptoms may be more useful than glaucopsia for constructing OELs for amine compounds in the future. Following the data in Table 6, a DMEA TWA-OEL of ≤2 ppm could be a safe level to prevent glaucopsia among workers. Visual disturbances can also occur in the presence of low air levels when exposure time is prolonged to hours before the onset of eye and skin irritations, and the consequences depend on the nature of the amine compound51). Korean workers complained of visual disturbances caused by TMHDA, but they were not suffering from irritation hazards in a PU foam factory31, 32).

Amine sampling and analytical methods

Determining airborne amine levels in the workplace atmosphere is relatively complex compared to that for organic solvents, such as toluene, xylene, and acetone. The sampling and analytical methods taken from various studies are listed in Table 7, and include recommended methods from US-OSHA, US-NIOSH, and UK-HSL. In constructing the table, authors, publication year, and method number are considered.

Table 7. Sampling and analytical methods for glaucopsia amines.

Reference Year Amines Sampling Analysis* Findings
Audursson & Mathiasson84) 1983 MMP, DMAEE Acid-filled impinger GC/TSD Testing for sampling/analytical measure

Audunsson & Mathiasson85) 1984 DMA, TEA, MMP - GC/TSD Testing for analytical measure

Hansén et al.86) 1985 DMEA Acid-filled impinger/Silica gel Isotachophoresis Comparing sampling/analytical measure

Hansén et al.87) 1986 MMP Acid-filled impinger Isotachophoresis Testing for sampling/analytical measure

Boeniger et al.72) 1987 TEDA Acid-filled impinger GC/TEA Impinger method could be complementary

Thermosorb/A

Andersson & Andersson88) 1989 DMEA, TEA Char coal tube GC/NPD & FID Charcoal for methyl/ethyl aliphatic amines


EMP Aberlite XAD-2 XAD-2 for long chain amines

Andersson & Andersson89) 1991 TEDA Aberlite XAD-2 GC/NPD XAD-2 is recommended for TEDA

Foley et al.90) 1991 TEA, DMAEE, EMP Thermosorb/A GC/NPD Thermosorb/A be use with caution

Rampel et al.91) 2008 TEA H3PO4 impregnated sampler LC/MS Testing for sampling/analytical measure

US-NIOSH NMAM 201092) 1994 Aliphatic amines Silica gel GC/FID Recommended method

US-NIOSH NMAM 200293) 1994 Aromatic amines Silica gel GC/FID Recommended method

US-NIOSH NMAM 200794) 1994 Aminoethanol compounds I Silica gel GC/FID Recommended method

US-NIOSH NMAM 350995) 1994 Aminoethanol compounds II Impinger with hexanesulfonic acid IC Recommended method

US-OSHA 3496) 1982 DMA 10% NBD chloride coated XAD-7 HPLC/Fl or Vis Recommended method

US-OSHA PV 206097) 1993 TEA 10% H3PO4 coated XAD-7 GC/FID Recommended method

US-OSHA PV 212398) 2003 MP 10% H3PO4 coated XAD-7 GC/FID Recommended method

US-OSHA IMIS 122599) NA NMP Silica gel GC/FID Recommended method

UK-HSL MDHS75/2100) NA Aromatic amines Acid-coated GF filter with Tenax HPLC/UV Recommended method

*GC/FID: Gas Chromatograph/Flame Ionization Detector, GC/MS: Gas Chromatograph/Mass Spectrometer, GC/NPD: Gas Chromatograph/Nitrogen Phosphorous Detector, GC/TEA: Gas Chromatograph/Thermal Energy Analyzer, 4GC/TSD: Gas Chromatograph/Thermionic Specific Detector, HPLC/Fl or Vis: High Performance Liquid Chromatograph/Florescence or Visible detector, HPLC/UV: High Performance Liquid Chromatograph/Ultraviolet detector, IC: Ion Chromatograph, LC/MS: Liquid Chromatograph/Mass Spectrometer.

During the 1980s, acid-filled impinges containing hydrochloric or sulfuric acid were widely used to capture amine compounds, as these chemicals had alkali characteristics72, 84, 86, 87, 91, 95). Subsequently, charcoal tubes were used for low molecular weight aliphatic amines88), XAD-288, 89) or XAD-796,97,98) was used for cyclic and long chain amines, silica gel92,93,94, 99) and acid-coated glass fiber filter were used with Tenax100), and Thermosorb/A72, 90) has been introduced in past decades. Acid-coated XAD tubes could effectively capture alkali and polar amine compounds. Thus, it is very difficult to recommend one versatile sampling medium for impregnating all types of amines; rather researchers should conduct laboratory tests for media that would be useful for their workplace monitoring program and target compounds.

For the instrumentations of amines, Gas Chromatograph has been widely adopted coupled with Flame Ionization Detector (FID), Nitrogen Phosphorous Detector (NPD), Thermal Energy Analyzer (TED) with nitrogen selective detector, Thermionic Specific Detector (TSD), and Mass Spectrometer (MS). Today High Performance Liquid Chromatography (HPLC) with Ultra Violet (UV) detector, fluorescence detector, visible light detector, Mass Selective Detector (MSD) are also commercially available in advanced laboratories. US-NIOSH recommends Ion Chromatography (IC) for some alkanol compounds95) and they have also tested HPLC for aromatic amines100). Although Hansén et al. suggested using isotachophoresis for analysis, it is not well accepted to analyze amine compounds, currently86, 87).

Mechanism of visual disturbances

Several researchers have attempted to identify the pathophysiology and mechanism of glaucopsia in animal and human experiments. Dernehl found diffuse corneal edema with vesicular fluid collections using slit-lamp microscopy in several Union Carbide workers who had been exposed to excessive levels of amine catalysts20). In their animal study, Mellerio & Weale reported that glaucopsia might be related to the Tyndall effect caused by denaturation of proteins in corneal epithelium43). Albrecht & Stephenson summarized that two distinct mechanisms, corneal edema and mydriasis with cycloplegia, could be the major reasons for the visual disturbances in response to some amines6). Brieger & Hodes, Belin et al. Akesson et al., and Järvinen et al. supported the occurrences of transient corneal edema22, 54,55,56, 101). Mydriasis and cycloplegia were reported by Watrous et al.3), Dernehel20), Goldberg & Johnson60) mainly before the 1960s; however, additional studies did not fully demonstrate the autonomous ganglion effects. Recently, Ballantyne reviewed occupational glaucopsia and concluded that local diffusion of amine vapors into the corneal surface caused epithelial edema with subepithelial microcysts and the water accumulation in the superficial cornea7). He also found that the systematic contribution to visual disturbances was small or negligible and that glaucopsia caused by exposure to amines did not cause chronic corneal damage.

Other health effects

These chemicals have demonstrated various effects on human health in addition to glaucopsia due to their chemical and physical characteristics. Some symptoms in humans include eye and respiratory track irritation, asthma, and headache80, 102,103,104,105,106). Amines may be causative agents in bronchial hyper-reactivity in PU factory workers. Belin et al. argued that isocyanates and amines might be responsible for respiratory symptoms among workers22). When the levels of other chemicals, such as isocyanate or formaldehyde, were relatively high during the 1970s and 1980s, apprehension about amines did not attract much attention in some scientific articles77, 78, 107).

Many studies have demonstrated the irritation effects of amines through human experience and animal testing77, 78, 108,109,110). Among them, some amines may not be found in the 21 names listed for this review due to relatively restricted information. The reference listing from this review may help occupational health researchers conducting studies on these topics (either human occupational studies or animal experiments). The articles referred in this section for animal experiments were also cited by other human glaucopsia studies referenced in this article.

Limitations and future

Despite the enormous effort to gather all articles and reports referenced in important studies, some valuable studies, such as case reports in factories in 1950s to the 1970s, could not be retrieved. Although this kind of limitation does not impart serious restrictions on this review, some information, such as process and hazardous level data, should have been obtained. Another limitation includes that some studies published in other languages, such as German, French, and Japanese might not be reviewed fully. Whether it was a inevitable publication bias for every scientist, some local data may be valuable, particularly if the information came from an advanced country with long-standing foundries and PU foam factories. The full text of some US-NIOSH studies15, 79, 107) could not be obtained, although abstracts were available. Although the human glaucopsia hazard is a relatively acute hazard and on-site follow-up studies may not be available, long-term epidemiological studies are necessary to detect sequelae from amine exposure and to prevent future risk.

Conclusion

Following the expansion of amine use during the past dozens of years, knowledge about occupational glaucopsia among workers engaged in the epoxy, foundry, and PU foam industries is valuable. Various amines, including TEA and DMEA, are reported to cause ocular hazards mainly creating conditions of diffused corneal edema and vesicular collection of fluid within subepithelial cells of the cornea. These visual effects occur 30 min to several hours after exposure to amines and the symptom last for several hours after termination of vapor exposure. Nevertheless, glaucopsia does not lead to permanent eye damage. The concentration-effect relationships have been established, from which it was inferred that concentration levels at worksites were critical to prevent the hazard. Visual disturbances may be a nuisance and not a life-threatening risk; however, they could predispose workers to occupational accidents, reduce coordinate performance, and impair work efficiency. While chemical manufacturers have been warning about visual disturbance from amines, occupational exposure criteria for many compounds are lacking. Volatility characteristics, such as VP, should be considered when new complex amines are introduced to industrial processes, such as printing shops, to prevent human ocular hazards including irritation effects.

References

  • 1.Cavender FL .(2012) Aliphatic and Alicyclic amines. In: Bingham E, Cohrssen B (Eds.), Patty’s industrial toxicology 6th Ed., Vol. II, 433–516, John Wiley & Sons, New York. [Google Scholar]
  • 2.Grant WM, Schuman JS. (1993) Toxicology of the eye: effect on the eyes and visual system form chemicals, drugs, metals and mineral, plants, toxins and venom, also systemic side effects from eye medications, 4th Ed. Charles C Thomas, Springfield. [Google Scholar]
  • 3.Watrous RM, Martins JK, Schulz HN. (1948) Two chlorinated tertiary amines (diethyl-β-chloroethyl amine and dimethyl-β-chloroethyl amine) toxicity in industrial use. Ind Med Surg 17, 237–41. [PubMed] [Google Scholar]
  • 4.Amor AJ. (1949) The toxicity of solvents. Manuf Chem Manuf Perfume 29, 540–4. [Google Scholar]
  • 5.Mailer CM. (1966) Glaucoma. An argument that began with Aristotle. Arch Ophthalmol 76, 623–6. [DOI] [PubMed] [Google Scholar]
  • 6.Albrecht WN, Stephenson RL. (1988) Health hazards of tertiary amine catalysts. Scand J Work Environ Health 14, 209–19. [DOI] [PubMed] [Google Scholar]
  • 7.Ballantyne B. (2004) Glaucopsia: an occupational ophthalmic hazard. Toxicol Rev 23, 83–90. [DOI] [PubMed] [Google Scholar]
  • 8.Jones WT, Kipling MD. (1972) Glaucopsia—blue-grey vision. Br J Ind Med 29, 460–1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cragle DL, Wells SM, Tankersley WG. (1992) An occupational morbidity study of population potentially exposed to epoxy resins, hardners, and solvents. Appl Occup Environ Hyg 7, 826–34. [Google Scholar]
  • 10.Warren DW, Jr, Selchan DF. (1988) An industrial hygiene appraisal of triethylamine and dimethylethylamine exposure limits in the foundry industry. Am Ind Hyg Assoc J 49, 630–4. [DOI] [PubMed] [Google Scholar]
  • 11.Schmitter H. (1977) Investigation of the cold-box and shell mold casting methods from the standpoint of occupational medicine and occupational hygiene. Giesserei 71, 895–902. [Google Scholar]
  • 12.US National Institute for Occupational Safety and Health (1984) Health Hazard Evaluation Report No. HETA 82-348-1442, The Dotson Company, Mankato, MN. US Department of Health and Human Services, Cincinnati.
  • 13.US National Institute for Occupational Safety and Health (1984) Health Hazard Evaluation Report No. HETA 80-081-1173, Keokuk Steel Castings Incorporated, Keokuk, IA. US Department of Health and Human Services, Cincinnati.
  • 14.US National Institute for Occupational Safety and Health (1986) Health Hazard Evaluation Report No. HETA 85-482-1730, 86-116-1730, Winter Industry Foundry, Canton, OH. US Department of Health and Human Services, Cincinnati.
  • 15.US National Institute for Occupational Safety and Health (1987) NTIS No 198815. US Department of Health and Human Services, Cincinnati. (Abstract). [Google Scholar]
  • 16.US National Institute for Occupational Safety and Health (1987) Preventing vision disturbances and acute physical distress due to dimethylethylamine (DMEA) exposure, DHHS publication No. 88–103. US Department of Health and Human Services, Cincinnati. [Google Scholar]
  • 17.Reilly MJ, Rosenman KD, Abrams JH, Zhu Z, Tseng C, Hertzberg V, Rice C. (1995) Ocular effects of exposure to triethylamine in the sand core cold box of a foundry. Occup Environ Med 52, 337–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Järvinen P, Hyvärinen L. (1997) Contrast sensitivity measurement in evaluations of visual symptoms caused by exposure to triethylamine. Occup Environ Med 54, 483–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mastromatteo E. (1965) Recent occupational health experiences in Ontario. J Occup Med 7, 502–11. [PubMed] [Google Scholar]
  • 20.Dernehl CU. (1966) Health hazards associated with polyurethane foams. J Occup Med 8, 59–62. [PubMed] [Google Scholar]
  • 21.Luckenbach M, Kielar R. (1980) Toxic corneal epithelial edema from exposure to high atmospheric concentration of toluene diisocyanates. Am J Ophthalmol 90, 682–6. [DOI] [PubMed] [Google Scholar]
  • 22.Belin L, Wass U, Audunsson G, Mathiasson L. (1983) Amines: possible causative agents in the development of bronchial hyperreactivity in workers manufacturing polyurethanes from isocyanates. Br J Ind Med 40, 251–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Åkesson B, Bengtsson M, Florén I. (1986) Visual disturbances after industrial triethylamine exposure. Int Arch Occup Environ Health 57, 297–302. [DOI] [PubMed] [Google Scholar]
  • 24.Potts AM, Rouse EF, Eiferman RA, Au PC. (1986) An unusual type of keratopathy observed in polyurethane workers and its reproduction in experimental animals. Am J Ind Med 9, 203–13. [DOI] [PubMed] [Google Scholar]
  • 25.US National Institute for Occupational Safety and Health (1995) Health Hazard Evaluation Report No. HETA 90-0277-2487, Johnson Controls, Greenfield, OH. US Department of Health and Human Services, Cincinnati.
  • 26.American Chemistry Council (2010) Health and safety product stewardship workbook for high-pressure application of spray polyurethane foam (SPF). http://spraypolyurethane.org/Workbook. Accessed February 20, 2015.
  • 27.US National Institute for Occupational Safety and Health (2002) Health Hazard Evaluation Report No. HETA 2001-0144-2867, Superior Label Systems, Manson, OH. US Department of Health and Human Services, Cincinnati.
  • 28.US National Institute for Occupational Safety and Health (2003) Health Hazard Evaluation Report No. HETA 2002-0379-2901, Superior Label Systems, Manson, OH. US Department of Health and Human Services, Cincinnati.
  • 29.Page EH, Cook CK, Hater MA, Mueller CA, Grote AA, Mortimer VD. (2003) Visual and ocular changes associated with exposure to two tertiary amines. Occup Environ Med 60, 69–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Yoshida T, Ono Y, Muto S, Nagaoka K, Taniwaki H, Imaeda T, Kamei T, Kurita H. (2001) Visual disturbances among workers exposed to triethylamine in a foundry in Japan. J Occup Health 43, 199–200. [Google Scholar]
  • 31.Jang J, Shin J, Lee N, Park H, Kwon J, Chung K .(2011) Resolution of halo vision cases by substitution of reactive amines in a polyurethane foaming industry. American Industrial Hygiene Conference and Exposition Poster (PS 404–3). Portland.
  • 32.Jang J, Park H. (2014) A case of worker’s exposure reductions for chemicals in a polyurethane pad process through the substitution of raw materials. J Kor Soc Occup Environ Hyg 24, 281–92. [Google Scholar]
  • 33.Treon JF, Sigmon H, Kitzmiller KV, Heyroth EF. (1949) The physiological response of animals to respiratory exposure to the vapors of diisopropylamine. J Ind Hyg Toxicol 31, 142–5. [PubMed] [Google Scholar]
  • 34.American Conference of Governmental Industrial Hygiene (2001) Documentation of Threshold Limit Values and Biological Exposure Indices: ethylamine. ACGIH, Cincinnati.
  • 35.Hathaway GJ, Proctor NH .(2004) Proctor and Hughes’ chemical hazards of the workplace: ethylamine. 5th Ed., 310, John Wiley & Sons, Hoboken. [Google Scholar]
  • 36.American Conference of Governmental Industrial Hygienists (2014) Threshold Limit Values for chemical substances and physical agents & biological exposure indices. ACGIH, Cincinnati.
  • 37.American Conference of Governmental Industrial Hygienists (2014) Guide to occupational exposure values. ACGIH, Cincinnati.
  • 38.Hathaway GJ, Proctor NH .(2004) Proctor and Hughes’ chemical hazards of the workplace: isopropylamine. 5th Ed., 415, John Wiley & Sons, Hoboken. [Google Scholar]
  • 39.American Conference of Governmental Industrial Hygiene (2001) Documentation of Threshold Limit Values and Biological Exposure Indices: isopropylamine. ACGIH, Cincinnati.
  • 40.Munn A. (1967) Health hazards in the chemical industry. Trans Soc Occup Med 17, 8–14. [DOI] [PubMed] [Google Scholar]
  • 41.American Conference of Governmental Industrial Hygiene (2004) Documentation of Threshold Limit Values and Biological Exposure Indices: ethylenediamine. ACGIH, Cincinnati.
  • 42.Hathaway GJ, Proctor NH .(2004) Proctor and Hughes’ chemical hazards of the workplace: ethylenediamine. 5th Ed., 318–9, John Wiley & Sons, Hoboken. [Google Scholar]
  • 43.Mellerio J, Weale RA. (1966) Hazy vision in amine plant operatives. Br J Ind Med 23, 153–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ballantyne B .(1999) Toxicology related to the eyes. In: Ballantyne B, Mars TC, Syversen T (Eds), General and applied toxicology, 2nd Ed., 737–4, Macmillan Reference, London. [Google Scholar]
  • 45.Hathaway GJ, Proctor NH .(2004) Proctor and Hughes’ chemical hazards of the workplace: dimethylamine. 5th Ed., 261–2, John Wiley & Sons, Hoboken. [Google Scholar]
  • 46.American Conference of Governmental Industrial Hygiene (2003) Documentation of Threshold Limit Values and Biological Exposure Indices: dimethylamine. ACGIH, Cincinnati.
  • 47.Hathaway GJ, Proctor NH .(2004) Proctor and Hughes’ chemical hazards of the workplace: diethylamine. 5th Ed., 247–8, John Wiley & Sons, Hoboken. [Google Scholar]
  • 48.American Conference of Governmental Industrial Hygiene (2013) Documentation of Threshold Limit Values and Biological Exposure Indices: diethylamine. ACGIH, Cincinnati.
  • 49.American Conference of Governmental Industrial Hygiene (2001) Documentation of Threshold Limit Values and Biological Exposure Indices: diisopropylamine. ACGIH, Cincinnati.
  • 50.Hathaway GJ, Proctor NH .(2004) Proctor and Hughes’ chemical hazards of the workplace: diisopropylamine. 5th Ed., 258, John Wiley & Sons, Hoboken. [Google Scholar]
  • 51.StÅhlbom B, Lundh T, Florén I, Akesson B. (1991) Visual disturbances in man as a result of experimental and occupational exposure to dimethylethylamine. Br J Ind Med 48, 26–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hathaway GJ, Proctor NH .(2004) Proctor and Hughes’ chemical hazards of the workplace: triethylamine, 5th Ed., 707–8, John Wiley & Sons, Hoboken. [Google Scholar]
  • 53.American Conference of Governmental Industrial Hygiene (2001) Documentation of Threshold Limit Values and Biological Exposure Indices: triethylamine. ACGIH, Cincinnati.
  • 54.Kesson BA, Florén I, Skerfving S. (1985) Visual disturbances after experimental human exposure to triethylamine. Br J Ind Med 42, 848–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Åkesson B, Skerfving S, Mattiasson L. (1988) Experimental study on the metabolism of triethylamine in man. Br J Ind Med 45, 262–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Järvinen P, Engström K, Riihimäki V, Ruusuvaara P, Setälä K. (1999) Effects of experimental exposure to triethylamine on vision and the eye. Occup Environ Med 56, 1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Åkesson B, Vinge E, Skerfving S. (1989) Pharmacokinetics of triethylamine and triethylamine-N-oxide in man. Toxicol Appl Pharmacol 100, 529–38. [DOI] [PubMed] [Google Scholar]
  • 58.Åkesson B, Skerfving S. (1990) Effects of ethanol ingestion and urinary acidity on the metabolism of triethylamine in man. Int Arch Occup Environ Health 62, 89–93. [DOI] [PubMed] [Google Scholar]
  • 59.Spaeth GL, Leopold IH. (1964) Ocular toxicity of dimethylaminopropylamine. Am J Ophthalmol 57, 632–8. [DOI] [PubMed] [Google Scholar]
  • 60.Goldberg ME, Johnson HE. (1962) Autonomic ganglion activity and acute toxicologic effects of N,N,N’,N’-tetramethyl-1, 3-butanediamine and triethylenediamine, two foam catalyst amines. Toxicol Appl Pharmacol 4, 522–45. [DOI] [PubMed] [Google Scholar]
  • 61.Ballantyne B. (2005) Bis [2-(dimethylamino)ethyl] ether (CH3) 2NCH2CH2OCH2CH2N (CH3) 2. J Appl Toxicol 25, 260–9. [DOI] [PubMed] [Google Scholar]
  • 62.Chun JS, Ballantyne B. (1997) Corneal thickness changes following exposure of New Zealand white rabbits to bis [2-(dimethylamino) ethyl] ether vapor. J Toxicol Cutaneous Ocul Toxicol 16, 239–52. [Google Scholar]
  • 63.Ballantyne B. (1997) The acute toxicity and irritancy of bis [2-(dimethylamino) ethyl] ether. Vet Hum Toxicol 39, 290–5. [PubMed] [Google Scholar]
  • 64.American Conference of Governmental Industrial Hygiene (2002) Documentation of Threshold Limit Values and Biological Exposure Indices: bis (2-dimethylaminoethyl) ether. ACGIH, Cincinnati.
  • 65.Hathaway GJ, Proctor NH .(2004) Proctor and Hughes’ chemical hazards of the workplace: morpholine. 5th Ed., 500, John Wiley & Sons, Hoboken. [Google Scholar]
  • 66.Reinhardt CF, Brittelli MR .(1981) Heterocyclic and miscellaneous nitrogen compounds: Morpholine. In: Clayton GD, Clayton FE (Eds.), Patty’s industrial hygiene and toxicology, 3th Ed., 2693–6, John Wiley & Sons, New York. [Google Scholar]
  • 67.American Conference of Governmental Industrial Hygiene (2001) Documentation of Threshold Limit Values and Biological Exposure Indices: morpholine. ACGIH, Cincinnati.
  • 68.Hathaway GJ, Proctor NH .(2004) Proctor and Hughes’ chemical hazards of the workplace: N-ethylmorpholine, 5th Ed., 337, John Wiley & Sons, Hoboken. [Google Scholar]
  • 69.American Conference of Governmental Industrial Hygiene (2001) Documentation of Threshold Limit Values and Biological Exposure Indices: N-ethylmorpholine. ACGIH, Cincinnati.
  • 70.Smith DB, Henderson R. (1975) Letter: TDI vapor concentrations. J Occup Med 17, 413–4. [PubMed] [Google Scholar]
  • 71.Pagnotto LD, Wegman DH. (1976) Letter: Exposure to triethylenediamine (TEDA) in urethane foam manufacture. J Occup Med 18, 523–4. [DOI] [PubMed] [Google Scholar]
  • 72.Boeniger MF, Choudhary G, Foley GD. (1987) Determination of airborne triethylenediamine and 2,2’-oxybis(N,N-dimethyl)ethylamine in the workplace. Apply Ind Hyg 2, 218–21. [Google Scholar]
  • 73.American Chemistry Council (2011) Polyurethane amine catalysts: safe handling guidelines. http://polyurethane.americanchemistry.com/resources-anddocument-library/3852.pdf. Accessed February 20, 2015.
  • 74.Ballantyne B, Leung HW. (1996) Acute toxicity and primary irritancy of alkylalkanolamines. Vet Hum Toxicol 38, 422–6. [PubMed] [Google Scholar]
  • 75.Malwitz N, Wong SW, Frisch KC, Manis PA. (1987) Amine catalysts of polyurethane foams. J Cell Plast 23, 461–502. [Google Scholar]
  • 76.Maris RV, Tamano Y, Yoshmura H, Gay KM. (2005) Polyurethane catalysts by tertiary amines. J Cell Plast 41, 305–22. [Google Scholar]
  • 77.US National Institute for Occupational Safety and Health (1987) Health Hazard Evaluation Report HETA 83-015-1809. Wellman Dynamics Corp., Creston, IA. US Department of Health and Human Services, Cincinnati.
  • 78.US National Institute for Occupational Safety and Health (1982) Health Hazard Evaluation Report No. HETA 83-131-1412. Midwest Foundry Coldwater, MI, US Department of Health and Human Services, Cincinnati.
  • 79.US National Institute for Occupational Safety and Health (1985) Health Hazard Evaluation Report HETA 80-073-1589. Marison Power Shovel. Marion, OH. US Department of Health and Human Services, Cincinnati. (Abstract).
  • 80.Low I, Mitchell C. (1985) Respiratory disease in foundry workers. Br J Ind Med 42, 101–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Savitt LE. (1955) Contact dermatitis encountered in the production of epoxy resins. AMA Arch Derm 71, 212–3. [DOI] [PubMed] [Google Scholar]
  • 82.Bourne LB, Milner FJM, Alberman KB. (1959) Health problems of epoxy resins and amine-curing agents. Br J Ind Med 16, 81–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.UK Health and Safety Executive (2011) EH40/2005 Workplace exposure limits, 2nd Ed. HSE, London.
  • 84.Audunsson G, Mathiasson L. (1983) Simultaneous determination of amines and isocyanates in working atmospheres by gas-liquid chromatography. J Chromatogr A 261, 253–64. [DOI] [PubMed] [Google Scholar]
  • 85.Audunsson G, Mathiasson L. (1984) Direct analysis of free amines in salt solutions at sub-ppm levels by gas-liquid chromatography. J Chrom 315, 299–312. [Google Scholar]
  • 86.Hansén L, Sollenberg J, Uggla C. (1985) Determination of dimethylethylamine in air samples from iron foundries by isotachophoresis. Scand J Work Environ Health 11, 307–10. [DOI] [PubMed] [Google Scholar]
  • 87.Hansén L, Åkesson B, Sollenberg J, Lundh T. (1986) Determination of N-methylmorpholine in air samples from a polyurethane foam factory. Comparison between two methods using gas chromatography and isotachophoresis for analysis. Scand J Work Environ Health 12, 66–9. [DOI] [PubMed] [Google Scholar]
  • 88.Andersson B, Andersson K. (1989) Determination of tertiary amines in air. Appl Ind Hyg 4, 175–9. [Google Scholar]
  • 89.Andersson B, Andersson K. (1991) Determination of heterocyclic tertiary amines in air. Appl Occup Environ Hyg 6, 40–3. [Google Scholar]
  • 90.Foley GD, Tucker SP, Cooper CV. (1991) Analysis of air for tertiary amine catalysts used in the polyurethane foam industry. Am Ind Hyg Assoc J 52, A664–5. [PubMed] [Google Scholar]
  • 91.Rampfl M, Mair S, Mayer F, Sedlbauer K, Breuer K, Niessner R. (2008) Determination of primary, secondary, and tertiary amines in air by direct or diffusion sampling followed by determination with liquid chromatography and tandem mass spectrometry. Environ Sci Technol 42, 5217–22. [DOI] [PubMed] [Google Scholar]
  • 92.US National Institute for Occupational Safety and HealthNIOSH Manual of Analytical Method 2010: aliphatic amines. http://www.cdc.gov/niosh/docs/2003-154/pdfs/2010.pdf. Accessed February 15, 2015.
  • 93.US National Institute for Occupational Safety and Health NIOSH Manual of Analytical Method 2010: aromatic amines. http://www.cdc.gov/niosh/docs/2003-154/pdfs/2002.pdf. Accessed February 15, 2015.
  • 94.US National Institute for Occupational Safety and Health NIOSH Manual of Analytical Method 2010: aminoethanol compound I. http://www.cdc.gov/niosh/docs/2003-154/pdfs/2007.pdf. Accessed February 15, 2015.
  • 95.US National Institute for Occupational Safety and Health NIOSH Manual of Analytical Method 2010: aminoethanol compound II. http://www.cdc.gov/niosh/docs/2003-154/pdfs/3509.pdf. Accessed February 15, 2015.
  • 96.US Occupational Safety and Health Administration Analytical method 34: dimethylamine. https://www.osha.gov/dts/sltc/methods/organic/org034/org034.html. Accessed February 15, 2015.
  • 97.US Occupational Safety and Health Administration Analytical method PV2060: trimethylamine. https://www.osha.gov/dts/sltc/methods/partial/pv2060/2060.html. Accessed February 15, 2015.
  • 98.US Occupational Safety and Health Administration Analytical method PV 2123: morpholine. https://www.osha.gov/dts/sltc/methods/partial/pv2123/pv2123.html. Accessed February 15, 2015.
  • 99.US Occupational Safety and Health Administration Analytical method IMIS 1225: N-ethylmorpholine. https://www.osha.gov/dts/chemicalsampling/data/CH_240640.html. Accessed February 15, 2015.
  • 100.UK Health and Safety Executive. Aromatic amines I air and on surfaces (MDHS75/2). http://www.hse.gov.uk/pubns/mdhs/pdfs/mdhs75-2.pdf. Accessed February 15, 2015.
  • 101.Brieger H, Hodes WA. (1951) Toxic effects of exposure to vapors of aliphatic amines. AMA Arch Ind Hyg Occup Med 3, 287–91. [PubMed] [Google Scholar]
  • 102.Lam S, Chan-Yeung M. (1980) Ethylenediamine-induced asthma. Am Rev Respir Dis 121, 151–5. [DOI] [PubMed] [Google Scholar]
  • 103.Candura F, Moscato G. (1984) Do amines induce occupational asthma in workers manufacturing polyurethane foams? Br J Ind Med 41, 552–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Ng TP, Lee HS, Malik MA, Chee CBE, Cheong TH, Wang YT. (1995) Asthma in chemical workers exposed to aliphatic polyamines. Occup Med (Lond) 45, 45–8. [DOI] [PubMed] [Google Scholar]
  • 105.Järvinen P. (1998) Headache and blood pressure among triethylamine-exposed foundry workers. Occup Med (Lond) 48, 113–7. [DOI] [PubMed] [Google Scholar]
  • 106.Bonauto DK, Sumner AD, Curwick CC, Whittaker SG, Lofgren DJ. (2005) Work-related asthma in the spray-on truck bed lining industry. J Occup Environ Med 47, 514–7. [DOI] [PubMed] [Google Scholar]
  • 107.US National Institute for Occupational Safety and Health (1976) Health Hazard Evaluation Report No. HETA 74-110-306. Morris Bean and Company, Yellow Springs, OH, US Department of Health and Human Services, Cincinnati (Abstract).
  • 108.Rockhold WT, Lansky H, Wright PG, Stokinger HE. (1956) The toxicities of tetramethyl propane diamine and tetramethyl propene diamine. Arch Ind Health 15, 124–33. [PubMed] [Google Scholar]
  • 109.Watrous RM, Schulz HN. (1950) Cyclohexylamine, p-chlornitrobenzene, 2-aminopyridine: toxic effects in industrial use. Ind Med Surg 19, 317–20. [PubMed] [Google Scholar]
  • 110.Klonne DR, Dodd DE, Pritts IM, Nachreiner DJ, Fowler EH, Troup CM, Homan ER, Ballantyne B. (1987) Dimethylethanolamine: acute, 2-week, and 13-week inhalation toxicity studies in rats. Fundam Appl Toxicol 9, 512–21. [DOI] [PubMed] [Google Scholar]

Articles from Industrial Health are provided here courtesy of National Institute of Occupational Safety and Health, Japan

RESOURCES